Aliases & Classifications for Cerebral Hemorrhage

MalaCards integrated aliases for Cerebral Hemorrhage:

Name: Cerebral Hemorrhage 37 28

Summaries for Cerebral Hemorrhage

MalaCards based summary : Cerebral Hemorrhage is related to cerebral amyloid angiopathy, cst3-related and hemorrhage, intracerebral, and has symptoms including sleeplessness, vertigo/dizziness and chronic pain. An important gene associated with Cerebral Hemorrhage is CST3 (Cystatin C), and among its related pathways/superpathways are Neuroscience and Copper homeostasis. The drugs Aspirin and Cilostazol have been mentioned in the context of this disorder. Affiliated tissues include brain, lung and bone, and related phenotypes are cardiovascular system and homeostasis/metabolism

Related Diseases for Cerebral Hemorrhage

Diseases related to Cerebral Hemorrhage via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 132)
# Related Disease Score Top Affiliating Genes
1 cerebral amyloid angiopathy, cst3-related 32.8 APP CST3 PRNP
2 hemorrhage, intracerebral 32.1 APP CST3
3 brain edema 29.4 IL1B SOD1
4 alzheimer disease 28.0 APP CST3 GFAP IL1B PRNP SOD1
5 cerebral amyloid angiopathy, app-related 12.1
6 eclampsia 11.2
7 cerebral cavernous malformations 10.8
8 thrombocytopenia 1 10.8
9 cerebritis 10.7
10 amyloidosis 10.4
11 binswanger's disease 10.1 APP GFAP
12 acute vascular insufficiency of intestine 10.0 IL1B SOD1
13 eales disease 10.0 IL1B SOD1
14 gerstmann-straussler disease 10.0 APP PRNP
15 tonsillitis 9.9 IL1B SOD1
16 aphasia 9.9 APP PRNP
17 pneumoconiosis 9.9 IL1B SOD1
18 hydrops, lactic acidosis, and sideroblastic anemia 9.8
19 dementia 9.8
20 encephalitis 9.8
21 vascular dementia 9.8 APP CST3 PRNP
22 dementia, lewy body 9.7 APP PRNP
23 aging 9.7
24 endocarditis 9.7
25 choriocarcinoma 9.7
26 ischemia 9.7 APP GFAP SOD1
27 prion disease 9.7 APP IL1B PRNP
28 leukoencephalopathy, hereditary diffuse, with spheroids 9.7 APP GFAP PRNP
29 scrapie 9.7 APP GFAP PRNP
30 multiple sclerosis 9.6
31 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 9.6
32 moyamoya disease 1 9.6
33 brain injury 9.6
34 leukemia 9.6
35 traumatic brain injury 9.6
36 infective endocarditis 9.6
37 thrombosis 9.6
38 nephrosclerosis 9.6
39 purpura 9.6
40 pancreatitis 9.6
41 pneumonia 9.6
42 neuronitis 9.6
43 herpes simplex 9.6
44 hemophilia 9.6
45 herpes simplex encephalitis 9.6
46 hereditary cerebral amyloid angiopathy 9.6
47 aneurysm 9.6
48 dysphagia 9.6
49 frontotemporal dementia 9.6 APP PRNP SOD1
50 maple syrup urine disease 9.6 GFAP SOD1

Graphical network of the top 20 diseases related to Cerebral Hemorrhage:



Diseases related to Cerebral Hemorrhage

Symptoms & Phenotypes for Cerebral Hemorrhage

UMLS symptoms related to Cerebral Hemorrhage:


sleeplessness, vertigo/dizziness, chronic pain, tremor, syncope, seizures, sciatica, pain, headache, edema, chest pain, back pain, angina pectoris

MGI Mouse Phenotypes related to Cerebral Hemorrhage:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.65 APP CST3 GFAP IL1B SOD1
2 homeostasis/metabolism MP:0005376 9.63 APP CST3 GFAP IL1B PRNP SOD1
3 muscle MP:0005369 9.35 APP CST3 GFAP PRNP SOD1
4 nervous system MP:0003631 9.1 APP CST3 GFAP IL1B PRNP SOD1

Drugs & Therapeutics for Cerebral Hemorrhage

Drugs for Cerebral Hemorrhage (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 304)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-78-2 2244
2
Cilostazol Approved, Investigational Phase 4,Phase 3 73963-72-1 2754
3
Probucol Approved, Investigational Phase 4 23288-49-5 4912
4
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 46507594 772
5
Nicardipine Approved, Investigational Phase 4,Phase 3,Phase 1 55985-32-5 4474
6
Dalteparin Approved Phase 4,Phase 2 9005-49-6
7 Nadroparin Approved, Investigational Phase 4 9041-08-1
8
Clevidipine Approved, Investigational Phase 4,Phase 3,Phase 2 167221-71-8
9
Warfarin Approved Phase 4,Phase 3 81-81-2 54678486 6691
10
Clopidogrel Approved Phase 4,Phase 3,Phase 2 120202-66-6, 113665-84-2 60606
11
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
12
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
13
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
14
Mannitol Approved, Investigational Phase 4 69-65-8 6251 453
15
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2
16
Amlodipine Approved Phase 4 88150-42-9 2162
17
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
18
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
19
Ethanol Approved Phase 4,Phase 1,Phase 2 64-17-5 702
20
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 5282452 6366718
21
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
22
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
23
Indapamide Approved Phase 4 26807-65-8 3702
24
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
25
Etomidate Approved Phase 4 33125-97-2 667484 36339
26
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
27
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
28
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
29
Succinylcholine Approved Phase 4 306-40-1 5314
30
Desflurane Approved Phase 4 57041-67-5 42113
31
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 5311068 56032 68602
32
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
33
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
34
Menadione Approved, Nutraceutical Phase 4,Phase 3,Early Phase 1 58-27-5 4055
35
Phytonadione Approved, Investigational, Nutraceutical Phase 4,Phase 3,Early Phase 1 84-80-0 5284607 4812
36 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
37
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
38
Caffeine Approved, Nutraceutical Phase 4,Phase 1,Phase 2 58-08-2 2519
39
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
40
Butyric Acid Experimental, Investigational Phase 4,Phase 2 107-92-6 264
41 Urapidil Investigational Phase 4,Phase 3 34661-75-1
42 Analgesics Phase 4,Phase 2,Phase 3,Phase 1
43 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1
44 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2
45 Anticholesteremic Agents Phase 4,Phase 2
46 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3,Phase 1
47 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 3,Phase 1
48 Antimetabolites Phase 4,Phase 2
49 Antioxidants Phase 4,Phase 2,Phase 3
50 Antipyretics Phase 4,Phase 2,Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 347)

# Name Status NCT ID Phase Drugs
1 Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Unknown status NCT01918722 Phase 4 ICH-1(herbal medicine with Hirudo, Tabanus);placebo;ICH-2(herbal medicine without Hirudo, Tabanus)
2 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Unknown status NCT01013532 Phase 4 Cilostazol;Probucol;Aspirin;placebo of cilostazol;placebo of aspirin
3 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Unknown status NCT02483169 Phase 4 cilostazol;Probucol;Aspirin;placebo of cilostazol;Placebo of aspirin
4 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
5 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4 Nicardipine
6 ASCEND: A Study of Cardiovascular Events iN Diabetes Unknown status NCT00135226 Phase 4 aspirin;Omega-3-acid Ethyl Esters;Placebo Aspirin;Placebo omega-3-Ethyl Esters
7 Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Unknown status NCT02224209 Phase 4
8 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4 Recombinant tissue plasminogen activator (rt-PA);Low Molecular Weight Heparin
9 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Unknown status NCT01042574 Phase 4 Clevidipine butyrate
10 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
11 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4 valproic acid;placebo bid
12 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4 Panax Notoginseng Saponins
13 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4 Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
14 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4 Clopidogrel;Clopidogrel placebo;Aspirin
15 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
16 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4 Caffeine citrate
17 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
18 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4 Olmesartan medoxomil;Calcium channel blockers (amlodipine, azelnidipine)
19 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
20 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4 Life style interventions plus concomitant use of pitavastatin.
21 Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Recruiting NCT03300479 Phase 4 Clevidipine;Urapidil
22 Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Recruiting NCT02699645 Phase 4 telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg;Placebo
23 Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Recruiting NCT03090113 Phase 4 Shuxuetong Injection;Placebo Injection
24 Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Not yet recruiting NCT03354026 Phase 4 AICH-PXZY;AICH-without PXZY;AICH-placebo
25 Study of Antithrombotic Treatment After Intracerebral Haemorrhage Not yet recruiting NCT03186729 Phase 4 Antithrombotic Agent
26 SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Not yet recruiting NCT03263117 Phase 4 Sedation;General Anesthesia (GA)
27 Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth Terminated NCT00295464 Phase 4 Betamethasone sodium phos (drug)
28 Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage Unknown status NCT00815737 Phase 2, Phase 3 rhubarb;Placebo
29 Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia Unknown status NCT01221142 Phase 3
30 Edoxaban for TIA and Acute Minor Stroke Unknown status NCT02221102 Phase 2, Phase 3 Aspirin;edoxaban;placebo
31 Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Unknown status NCT01923818 Phase 2, Phase 3 rivaroxaban;Aspirin;placebo
32 Management of Hypotension In the Preterm Infant Unknown status NCT01482559 Phase 3 Dopamine hydrochloride;Dextrose 5%
33 Cilostazol Stroke Prevention Study for Antiplatelet Combination Unknown status NCT01995370 Phase 3 aspirin;clopidogrel;cilostazol
34 Recombinant Factor VIIa in Acute Intracerebral Haemorrhage Completed NCT00127283 Phase 3 eptacog alfa (activated)
35 Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE) Completed NCT00666328 Phase 3 clevidipine
36 A Randomised Controlled Trial of Lumbar Drainage to Treat Communicating Hydrocephalus After Severe Intraventricular Hemorrhage Completed NCT01041950 Phase 2, Phase 3
37 Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial Completed NCT00041938 Phase 3 aspirin;Warfarin
38 Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Completed NCT00784134 Phase 3 Alteplase
39 Secondary Prevention of Small Subcortical Strokes Trial Completed NCT00059306 Phase 3 aspirin;clopidogrel
40 Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) Completed NCT00129805 Phase 3 MCI-9042;Aspirin
41 Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick Completed NCT02270151 Phase 3
42 Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke Completed NCT01949948 Phase 3 Tenecteplase;Alteplase
43 Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial Completed NCT00033917 Phase 3 indomethacin;placebo
44 Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage Completed NCT00009620 Phase 3 Phenobarbital;Saline
45 Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate Completed NCT00262600 Phase 3 warfarin;Dabigatran dose 1;Dabigatran dose 2
46 Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence Completed NCT00562289 Phase 3 aspirin;Antivitamins K or rivaroxaban or dabigatran or apixaban
47 Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) Completed NCT00014989 Phase 3 magnesium sulfate
48 REstart or STop Antithrombotic Randomised Trial in France Recruiting NCT02966119 Phase 3 Clopidogrel or Aspirin and/or Dypyridamole
49 Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist Recruiting NCT02866838 Phase 2, Phase 3 Tranexamic acid;Saline 0.9%
50 Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S) Recruiting NCT03290053 Phase 3 SonoVue;Sodium chloride

Search NIH Clinical Center for Cerebral Hemorrhage

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Cerebral Hemorrhage cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Cerebral Hemorrhage:
GLP-1 CellBeads
Embryonic/Adult Cultured Cells Related to Cerebral Hemorrhage:
GLP-transfected mesenchymal stem cells PMIDs: 22985173 22034462

Genetic Tests for Cerebral Hemorrhage

Genetic tests related to Cerebral Hemorrhage:

# Genetic test Affiliating Genes
1 Cerebral Hemorrhage 28

Anatomical Context for Cerebral Hemorrhage

MalaCards organs/tissues related to Cerebral Hemorrhage:

38
Brain, Lung, Bone, Heart, Bone Marrow, Testes, Neutrophil

Publications for Cerebral Hemorrhage

Articles related to Cerebral Hemorrhage:

(show top 50) (show all 267)
# Title Authors Year
1
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy). ( 29433151 )
2018
2
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. ( 29247070 )
2018
3
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell-cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility. ( 29017932 )
2018
4
Letter by Chang et al Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183951 )
2018
5
Response by Fouda and Switzer to Letter Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183950 )
2018
6
Recurrent Cerebral Hemorrhage in Normal Pregnancy Secondary to Mycotic Pseudoaneurysms Related to Choriocarcinoma. ( 28987845 )
2018
7
Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial. ( 28887388 )
2017
8
Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention. ( 28342065 )
2017
9
Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. ( 28595677 )
2017
10
Author's Response to Letter to the Editor: Cerebral Hemorrhage Following Chiropractic Activator Treatment-Case Report and Review of the Literature. ( 29034908 )
2017
11
Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: AA Prospective Cohort Study. ( 28969928 )
2017
12
Fatal cerebral hemorrhage associated with acute pancreatitis: A case report. ( 29390292 )
2017
13
Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis. ( 28720659 )
2017
14
Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab. ( 28447276 )
2017
15
Letter by Tsivgoulis et al Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis". ( 29030473 )
2017
16
Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy. ( 28090058 )
2017
17
Cerebral hemorrhage in monozygotic twins with hereditary hemorrhagic telangiectasia: case report and hemorrhagic risk evaluation. ( 28524787 )
2017
18
Cerebral hemorrhage therapy by targeting VEGF and HGF in a preclinical trial in rats. ( 28339025 )
2017
19
A Case Report of Maternal Cerebral Hemorrhage in Preterm Pregnancy. ( 28599120 )
2017
20
Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study. ( 28739344 )
2017
21
A Systematic Review and Meta-Analysis on the Treatment of Cerebral Hemorrhage with NaoXueShu Oral Liquid. ( 28630871 )
2017
22
Cerebral Hemorrhage following Chiropractic Activator Treatment: Case Report and Review of Literature. ( 28884069 )
2017
23
Cerebral hemorrhage as the initial manifestation in patients with systemic cancer. ( 28724319 )
2017
24
Letter to the Editor: Cerebral Hemorrhage following Chiropractic Activator Treatment-Case Report and Review of Literature. ( 29027546 )
2017
25
Response by Werring and Charidimou to Letter Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis". ( 29030477 )
2017
26
Cumulative meta-analysis of intensive blood-pressure lowering in acute cerebral hemorrhage: Quo vadis? ( 28320125 )
2017
27
Hypertensive Cerebral Hemorrhage in a Patient with Turner Syndrome Caused by Deletion in the Short Arm of the X Chromosome. ( 29275412 )
2017
28
Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. ( 28915688 )
2017
29
Investigation on Risk Factors of Ventilator-Associated Pneumonia in Acute Cerebral Hemorrhage Patients in Intensive Care Unit. ( 29391844 )
2017
30
Discovery of a ROCK inhibitor, FPND, which prevents cerebral hemorrhage through maintaining vascular integrity by interference with VE-cadherin. ( 28845297 )
2017
31
Effects of Acupuncture on mRNA Levels of Apoptotic Factors in Perihematomal Brain Tissue During the Acute Phase of Cerebral Hemorrhage. ( 28357997 )
2017
32
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. ( 28356458 )
2017
33
Sjogren's syndrome complicating pancytopenia, cerebral hemorrhage, and damage in nervous system: A case report and literature review. ( 29390256 )
2017
34
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies. ( 28605557 )
2017
35
TGFI^ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type. ( 28557134 )
2017
36
Contrast extravasation through MRI precedes cerebral hemorrhage in a patient with eclampsia. ( 27885447 )
2016
37
Methanol intoxication with cerebral hemorrhage. ( 27356664 )
2016
38
The correlation between blood calcium level, hematoma volume, stroke severity and prognosis in patients with acute cerebral hemorrhage. ( 27775786 )
2016
39
Association of protein Z and factor VII gene polymorphisms with risk of cerebral hemorrhage: a case-control and a family-based association study in a Chinese Han population. ( 27350683 )
2016
40
Guillain-BarrAc Syndrome and Cerebral Hemorrhage: Two Cases and Literature Review. ( 27669485 )
2016
41
Nao-Xue-Shu Oral Liquid Protects and Improves Secondary Brain Insults of Hypertensive Cerebral Hemorrhage. ( 27110267 )
2016
42
Dengue fever with diffuse cerebral hemorrhages, subdural hematoma and cranial diabetes insipidus. ( 27165581 )
2016
43
Clinical Features of Liver Cancer with Cerebral Hemorrhage. ( 27209058 )
2016
44
Clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage. ( 27375713 )
2016
45
The protective and hemodynamic effects of dexmedetomidine on hypertensive cerebral hemorrhage patients in the perioperative period. ( 27882094 )
2016
46
Adjuvant-induced mono-arthritis potentiates cerebral hemorrhage in the spontaneously hypertensive rats. ( 26903291 )
2016
47
Bilateral Cerebral Hemorrhage in Herpes Simplex Encephalitis: Rare Occurrence. ( 28163530 )
2016
48
Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke. ( 27018013 )
2016
49
Blood pressure in acute intra-cerebral hemorrhage. ( 27668240 )
2016
50
HSV-2 encephalitis complicated by cerebral hemorrhage in an immunocompetent person. ( 26878968 )
2016

Variations for Cerebral Hemorrhage

Expression for Cerebral Hemorrhage

Search GEO for disease gene expression data for Cerebral Hemorrhage.

Pathways for Cerebral Hemorrhage

Pathways related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.55 APP CST3 GFAP PRNP SOD1
2 11.06 APP PRNP SOD1
3 10.74 APP PRNP
4 10.68 IL1B PRNP SOD1
5 10.62 APP CST3

GO Terms for Cerebral Hemorrhage

Cellular components related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 secretory granule GO:0030141 9.16 IL1B SOD1
2 astrocyte projection GO:0097449 8.96 APP GFAP
3 lysosome GO:0005764 8.92 CST3 GFAP IL1B SOD1

Biological processes related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 cellular response to oxidative stress GO:0034599 9.58 CST3 SOD1
2 locomotory behavior GO:0007626 9.57 APP SOD1
3 positive regulation of JNK cascade GO:0046330 9.56 APP IL1B
4 cellular response to drug GO:0035690 9.55 IL1B PRNP
5 response to nutrient levels GO:0031667 9.54 CST3 SOD1
6 learning or memory GO:0007611 9.52 APP PRNP
7 response to axon injury GO:0048678 9.51 CST3 SOD1
8 regulation of multicellular organism growth GO:0040014 9.49 APP SOD1
9 cellular response to amyloid-beta GO:1904646 9.48 APP PRNP
10 positive regulation of NF-kappaB import into nucleus GO:0042346 9.46 APP IL1B
11 response to copper ion GO:0046688 9.43 PRNP SOD1
12 cellular copper ion homeostasis GO:0006878 9.4 APP PRNP
13 response to carbohydrate GO:0009743 9.37 CST3 IL1B
14 negative regulation of long-term synaptic potentiation GO:1900272 9.32 APP PRNP
15 modulation of age-related behavioral decline GO:0090647 9.26 APP PRNP
16 neuron projection maintenance GO:1990535 9.16 APP PRNP
17 embryo implantation GO:0007566 9.13 CST3 IL1B SOD1
18 response to oxidative stress GO:0006979 8.92 APP CST3 PRNP SOD1

Molecular functions related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chaperone binding GO:0051087 9.26 PRNP SOD1
2 amyloid-beta binding GO:0001540 9.16 CST3 PRNP
3 identical protein binding GO:0042802 9.02 APP CST3 GFAP PRNP SOD1
4 copper ion binding GO:0005507 8.96 PRNP SOD1

Sources for Cerebral Hemorrhage

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....